Glenmark bullish on drug discovery pipeline, eyes partnerships
As many as six out of seven molecules in Glenmark's drug discovery pipeline are currently in the clinical trial stage and the company's R&D spend pegged at 10 percent of sales is expected to be maintained at similar levels for next two years, a top official has said.
Feb 15, 2015, 20:55 PM ISTGlenmark bullish on drug discovery pipeline, eyes partnerships
Pain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing Director, Glenmark Pharmaceuticals Ltd.
Feb 15, 2015, 11:00 AM IST